We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Postmenopausal women with normoglycemia with a first-degree family history of diabetes (FHD) have elevated bone mineral density (BMD), according to a study published online in Menopause.
Tenofovir preexposure prophylaxis (PrEP) therapy does not appear to be associated with clinically significant declines in bone mineral density (BMD) in the short term...